Autoimmune Disease Diagnostics Market Size Will Become USD 10.3 Billion by 2032
April 18, 2023 06:09 ET
|
Market.Us
New York, April 18, 2023 (GLOBE NEWSWIRE) -- The global autoimmune disease diagnostics market size accounted for USD 5.3 billion in 2022 and it is projected to surpass around USD 10.3 billion by...
Monoclonal Antibody Therapeutics Market to Surpass US$ 534.26 Billion by 2030, Says Coherent Market Insights (CMI)
April 12, 2023 08:40 ET
|
CMI
Burlingame, April 12, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, Global Monoclonal Antibody Therapeutics Market is estimated to be valued at US$ 205.39 Billion in 2023 and is...
Autoimmune Disease Testing Market is set to reach revenue of US$ 15.75 Billion, expected to grow at 10% CAGR during 2023 to 2033 period | Future Market Insights, Inc.
April 10, 2023 03:55 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, April 10, 2023 (GLOBE NEWSWIRE) -- According to FMI estimations, the Autoimmune Disease Testing Market could increase from US$ 6.07 billion in 2023 to US$ 15.75 billion by 2033. The...
With 10% CAGR, Autoimmune Disease Testing Market Size to Surpass USD 10.75 Billion by 2029
February 01, 2023 05:03 ET
|
Fortune Business Insights
Pune, India, Feb. 01, 2023 (GLOBE NEWSWIRE) -- The global autoimmune disease testing market size was valued at USD 4.84 billion in 2021. The market is projected to grow from USD 5.52 billion in 2022...
Autoimmune Disease Diagnostics Market Worth $7.53 Billion by 2029 - Exclusive Report by Meticulous Research®
December 15, 2022 10:00 ET
|
Meticulous Market Research Pvt. Ltd.
Redding, California, Dec. 15, 2022 (GLOBE NEWSWIRE) -- According to a new market research report titled, ‘Autoimmune Disease Diagnostics Market by Product (Reagents, Kits, Assays, Instruments),...
Autoimmune Disease Diagnostics Market Size Worth USD 7.2 Billion by 2030 at 6.7% CAGR – Report by Market Research Future (MRFR)
October 20, 2022 11:30 ET
|
Market Research Future
New York, USA, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Autoimmune Disease Diagnostics Market Overview: According to a Comprehensive Research Report by Market Research Future (MRFR), “Autoimmune...
Exagen Announces Appointment of Andrew L. Concoff MD, FACR, CAQSM, as Chief Innovation Officer
October 04, 2022 08:25 ET
|
Exagen Inc.
SAN DIEGO, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced the appointment of Andrew L. Concoff M.D. FACR, CAQSM as...
Exagen Announces Acceptance of Multiple Abstracts at ACR 2022 Annual Meeting
September 20, 2022 16:05 ET
|
Exagen Inc.
SAN DIEGO, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today the acceptance of nine abstracts at the 2022 American...
Exagen Inc. Collaboration Leads to Characterization of Broad Autoreactivity in Severe COVID-19 Patients
September 01, 2022 16:05 ET
|
Exagen Inc.
SAN DIEGO, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that its collaboration with Dr. Iñaki Sanz at Emory...
Allsup Supports “Walk To End Lupus Now 2022” with LFA Heartland Chapter On Saturday, Sept. 10
August 31, 2022 14:12 ET
|
Allsup
Belleville, Illinois, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Allsup, the nation’s premier disability representation company®, is proud to be sponsoring the “Walk To End Lupus Now 2022-St. Louis”...